Vident Investment Advisory’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-5,396
| Closed | -$550K | – | 1122 |
|
|
2023
Q2 | $550K | Buy |
5,396
+968
| +22% | +$98.6K | 0.02% | 663 |
|
|
2023
Q1 | $783K | Buy |
4,428
+911
| +26% | +$161K | 0.03% | 605 |
|
|
2022
Q4 | $1.36M | Sell |
3,517
-71
| -2% | -$27.5K | 0.05% | 414 |
|
|
2022
Q3 | $1.21M | Buy |
3,588
+238
| +7% | +$80.2K | 0.04% | 526 |
|
|
2022
Q2 | $1.1M | Buy |
3,350
+350
| +12% | +$115K | 0.03% | 589 |
|
|
2022
Q1 | $1.31M | Buy |
3,000
+1,295
| +76% | +$566K | 0.03% | 599 |
|
|
2021
Q4 | $748K | Buy |
1,705
+67
| +4% | +$29.4K | 0.02% | 814 |
|
|
2021
Q3 | $911K | Buy |
+1,638
| New | +$911K | 0.03% | 708 |
|